Litcius/Paper detail

The degradation of gelatin/alginate/fibrin hydrogels is cell type dependent and can be modulated by targeting fibrinolysis

Elea Boucard, Luciano Vidal, Flora Coulon, Carlos Mota, Jean-Yves Hascoët, Franck Halary

2022Frontiers in Bioengineering and Biotechnology20 citationsDOIOpen Access PDF

Abstract

In tissue engineering, cell origin is important to ensure outcome quality. However, the impact of the cell type chosen for seeding in a biocompatible matrix has been less investigated. Here, we investigated the capacity of primary and immortalized fibroblasts of distinct origins to degrade a gelatin/alginate/fibrin (GAF)-based biomaterial. We further established that fibrin was targeted by degradative fibroblasts through the secretion of fibrinolytic matrix-metalloproteinases (MMPs) and urokinase, two types of serine protease. Finally, we demonstrated that besides aprotinin, specific targeting of fibrinolytic MMPs and urokinase led to cell-laden GAF stability for at least forty-eight hours. These results support the use of specific strategies to tune fibrin-based biomaterials degradation over time. It emphasizes the need to choose the right cell type and further bring targeted solutions to avoid the degradation of fibrin-containing hydrogels or bioinks.

Topics & Concepts

FibrinFibrinolysisGelatinSelf-healing hydrogelsPlasminChemistryMatrix metalloproteinaseAprotininSerine proteaseCellCell biologyBiomedical engineeringProteaseBiochemistryImmunologyMedicineBiologyInternal medicineEnzymePolymer chemistryPeriodontal Regeneration and Treatments3D Printing in Biomedical ResearchElectrospun Nanofibers in Biomedical Applications